These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 3161759

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mal de Meleda: recessive transgressive palmoplantar keratoderma with three unusual facultative features.
    Lestringant GG, Hadi SM, Qayed KI, Blayney BJ.
    Dermatology; 1992; 184(1):78-82. PubMed ID: 1532755
    [Abstract] [Full Text] [Related]

  • 4. Clinical and genetic studies of 3 large, consanguineous, Algerian families with Mal de Meleda.
    Bouadjar B, Benmazouzia S, Prud'homme JF, Cure S, Fischer J.
    Arch Dermatol; 2000 Oct; 136(10):1247-52. PubMed ID: 11030771
    [Abstract] [Full Text] [Related]

  • 5. [Mal de Meleda. 16 cases].
    Marrakchi Z, Marrachi S, Meziou TJ, Turki H, Zahaf A.
    Tunis Med; 2006 Jul; 84(7):423-6. PubMed ID: 17039733
    [Abstract] [Full Text] [Related]

  • 6. Hereditary palmoplantar keratoderma and dermatophytosis in the northernmost county of Sweden (Norrbotten).
    Nielsen PG.
    Acta Derm Venereol Suppl (Stockh); 1994 Jul; 188():1-60. PubMed ID: 9868488
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Malignant melanoma developing in an area of hereditary palmoplantar keratoderma (Mal de Meleda).
    Mozzillo N, Nunziata CA, Caracò C, Fazioli F, Botti G, Melanoma Cooperative Group.
    J Surg Oncol; 2003 Dec; 84(4):229-33. PubMed ID: 14756434
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A novel homozygous mutation disrupting the initiation codon in the SLURP1 gene underlies mal de Meleda in a consanguineous family.
    Shah K, Nasir A, Irfanullah, Shahzad S, Khan S, Ahmad W.
    Clin Exp Dermatol; 2016 Aug; 41(6):675-679. PubMed ID: 29226984
    [Abstract] [Full Text] [Related]

  • 12. Etretinate: management of keratoma hereditaria mutilans in four family members.
    Rivers JK, Duke EE, Justus DW.
    J Am Acad Dermatol; 1985 Jul; 13(1):43-9. PubMed ID: 3161912
    [Abstract] [Full Text] [Related]

  • 13. Mutilating palmoplantar keratoderma successfully treated with etretinate.
    Wereide K.
    Acta Derm Venereol; 1984 Jul; 64(6):566-9. PubMed ID: 6084939
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. SLURP1 mutation-impaired T-cell activation in a family with mal de Meleda.
    Tjiu JW, Lin PJ, Wu WH, Cheng YP, Chiu HC, Thong HY, Chiang BL, Yang WS, Jee SH.
    Br J Dermatol; 2011 Jan; 164(1):47-53. PubMed ID: 20854438
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mal de meleda with lip involvement: a report of two cases.
    Nath AK, Chaudhuri S, Thappa DM.
    Indian J Dermatol; 2012 Sep; 57(5):390-3. PubMed ID: 23112362
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.